Your shopping cart is empty

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

Check out our free and informative ezines and sign up now

Home > Newsletters > FDAnews Device Daily Bulletin > St. Jude Medical’s Peripheral Nerve Stimulation Study Confirms Benefit for Chronic Migraine Patients

FDAnews Device Daily Bulletin

Oct. 4, 2012 | Vol. 9 No. 195

St. Jude Medical’s Peripheral Nerve Stimulation Study Confirms Benefit for Chronic Migraine Patients

St. Jude Medical announced publication of results from the first large-scale study of peripheral nerve stimulation of the occipital nerves in patients suffering from chronic migraine.
MarketWatch

Register Now
Print This Page
Email This Article
RSS
Archives

Chip Identifies Bacterial Infection in Minutes, Not Days The New Battlefield for Medical Device Litigation FDA Clears Orthosensor's Verasense Knee Replacement Device Ten Takeaways From FDA's 2013 Warning and Untitled Letters

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.